###begin article-title 0
Rosiglitazone Prevents High Glucose-Induced Vascular Endothelial Growth Factor and Collagen IV Expression in Cultured Mesangial Cells
###end article-title 0
###begin p 1
Recommended by Mark Cooper
###end p 1
###begin p 2
###xml 48 53 48 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 200 205 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 465 470 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 559 563 547 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 595 599 583 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
###xml 669 674 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 901 906 882 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 977 981 954 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
###xml 354 357 <span type="species:ncbi:10116">rat</span>
Peroxisome proliferator-activated receptor (PPARgamma), a ligand-dependent transcription factor, negatively modulates high glucose effects. We postulated that rosiglitazone (RSG), an activator of PPARgamma prevents the upregulation of vascular endothelial growth factor (VEGF) and collagen IV by mesangial cells exposed to high glucose. Primary cultured rat mesangial cells were growth-arrested in 5.6 mM (NG) or 25 mM D-glucose (HG) for up to 48 hours. In HG, PPARgamma mRNA and protein were reduced within 3 h, and enhanced ROS generation, expression of p22phox, VEGF and collagen IV, and PKC-zeta membrane association were prevented by RSG. In NG, inhibition of PPARgamma caused ROS generation and VEGF expression that were unchanged by RSG. Reduced AMP-activated protein kinase (AMPK) phosphorylation in HG was unchanged with RSG, and VEGF expression was unaffected by AMPK inhibition. Hence, PPARgamma is a negative modulator of HG-induced signaling that acts through PKC-zeta but not AMPK and regulates VEGF and collagen IV expression by mesangial cells.
###end p 2
###begin title 3
1. Introduction
###end title 3
###begin p 4
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 508 512 508 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 514 515 511 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 517 518 514 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 765 766 762 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 768 769 765 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
The hallmark of progressive diabetic glomerulosclerosis is the accumulation of excessive extracellular matrix protein (ECM), mainly collagen IV, in the glomerular interstitium [1, 2]. This results in large part from the transformation of quiescent mesangial cells to a dedifferentiated myofibroblast phenotype as a result of the direct effects of high glucose and the response to autocrine and paracrine growth factors including vascular endothelial growth factor (VEGF) and transforming growth factor (TGF)-beta [3, 4]. We and others have demonstrated that early mesangial cell responses to high glucose include the generation of reactive oxygen species (ROS) from NADPH oxidase, a necessary signaling factor in the stimulation of VEGF and collagen IV expression [3, 5]. 
###end p 4
###begin p 5
###xml 79 85 79 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947; </italic>
###xml 91 96 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 223 224 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 226 227 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 234 239 226 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 356 361 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 514 515 498 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 522 527 506 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 668 669 648 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 686 688 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 736 741 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 809 814 785 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 889 894 861 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 931 936 899 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 958 962 922 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 962 963 923 924 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 965 967 926 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 981 983 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1110 1112 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1122 1126 1083 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1126 1127 1084 1085 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1129 1131 1087 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 704 707 <span type="species:ncbi:10116">rat</span>
 Recent studies have suggested that peroxisome proliferator-activated receptor-gamma  (PPARgamma) synthetic agonist thiazolidinediones, such as rosiglitazone, may prevent or attenuate diabetic nephropathy in animal models [6, 7]. PPARgamma is a member of the nuclear receptor superfamily of ligand-activated transcription factors. Upon ligand binding, PPARgamma forms a heterodimer with the retinoic X receptor. This complex then binds to PPAR response elements (PPREs) within the promoter region of target genes [8]. PPARgamma agonists have been shown to play an important role in regulating adipocyte differentiation, lipid and glucose metabolism, and inflammation [9]. Asano et al. [10] reported that rat mesangial cells express PPARgamma localized in the nucleus, and that troglitazone (an agonist of PPARgamma) prevents cellular dedifferentiation as detected by reduced expression of alpha-smooth muscle actin expression. PPARgamma agonists inhibit TGF-beta1 [11] and Ang II [12] stimulation of vascular smooth muscle cells, and mesangial cell proliferation and fibronectin synthesis in response to VEGF [13] and TGF-beta1 [14], respectively. 
###end p 5
###begin p 6
###xml 152 156 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 165 169 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
###xml 225 227 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 252 254 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 339 344 333 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 424 426 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 709 714 699 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 282 286 <span type="species:ncbi:10116">rats</span>
We have demonstrated that in response to high glucose, mesangial cells rapidly express and secrete VEGF that is dependent on the activation of both PKC-beta and PKC-zeta, and the generation of reactive oxygen species (ROSs) [15]. Yang et al. reported [16] that hyperglycemic Zucker rats develop increased circulating VEGF and that the PPARgamma agonist pioglitazone normalized serum glucose and VEGF levels. Onozaki et al. [13] showed that during exposure to a rapid change in ambient glucose concentration, mesangial cell proliferation dependent on VEGF expression was inhibited by a thiazolidinedione. The cellular signaling mechanisms that connect the effects of high glucose to altered mesangial cell PPARgamma expression and function and consequent outcomes relevant to progressive glomerulosclerosis are unknown. 
###end p 6
###begin p 7
###xml 275 280 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 608 613 604 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 713 718 705 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 967 972 955 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1085 1087 1069 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1178 1183 1162 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
In this study, we postulated that rosiglitazone would reverse the effects of high glucose essential for the early responses of mesangial cells associated with myofibroblast transformation including ROS generation, VEGF and collagen IV expression. To identify the role of PPARgamma in mesangial cells, we tracked its expression and the effects of rosiglitazone during exposure to high glucose. The actions of rosiglitazone on high glucose-stimulated ROS generation via NADPH oxidase and the expression of VEGF and collagen IV were observed. These effects were confirmed by similar findings with two other PPARgamma agonists, Ciglitazone and Troglitazone. Supporting these observations, a specific inhibitor of PPARgamma, GW9662, on mesangial cell expression of VEGF in normal glucose and high glucose had opposite effects. To determine whether AMP-activated protein kinase (AMPK), reported to be activated by thiazolidinediones, is involved in this mesangial cell PPARgamma pathway, the phosphorylation of AMPK was analyzed in the presence of Compound C, a specific antagonist of AMPK [17], with and without rosiglitazone. Our data support a major role for downregulation of PPARgamma during the early response of mesangial cells to high glucose and reversal with rosiglitazone. 
###end p 7
###begin title 8
2. Materials and Methods
###end title 8
###begin title 9
2.1. Materials
###end title 9
###begin p 10
###xml 209 210 209 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 317 321 317 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 370 375 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 480 484 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 598 603 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 50 56 <span type="species:ncbi:9913">bovine</span>
###xml 277 283 <span type="species:ncbi:9986">Rabbit</span>
###xml 546 552 <span type="species:ncbi:9986">Rabbit</span>
###xml 678 684 <span type="species:ncbi:9986">rabbit</span>
Dulbecco's modified Eagle medium (DMEM) and fetal bovine serum (FBS) were purchased from Invitrogen Corporation (Burlington, Ont, Canada). 5-(and-6)-chlormethyl-2',7'-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) was obtained from Molecular Probes Inc. (Eugene, Ore, USA). Rabbit Polyclonal antibodies against p22phox and VEGF, and monoclonal antibodies against PPARgamma were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, Calif, USA). Monoclonal antibody against beta-actin was purchased from Sigma-Aldrich (St, Louis, Mo, USA). Rabbit polyclonal antibody against type IV collagen alpha was purchased from Rockland Immunochemicals (Gilbertsville, Pa, USA). The rabbit polyclonal antibodies against phospho- and total-AMPK alpha were purchased from Cell Signaling Technology, Inc. (Danvers, Mass, USA). The selective ATP-competitive inhibitor of AMPK, Compound C, and Ciglitazone were purchased from Calbiochem (Gibbstown, NJ, USA). Rosiglitazone and Troglitazone and GW9662 were purchased from Cayman Chemical (Ann Arbor, Mich, USA).
###end p 10
###begin title 11
2.2. Cell Culture
###end title 11
###begin p 12
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 415 417 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 437 439 436 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 457 459 455 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 501 503 498 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 519 524 515 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 688 690 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 692 694 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 696 698 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 8 11 <span type="species:ncbi:10116">rat</span>
###xml 58 76 <span type="species:ncbi:10116">Sprague-Dawley rat</span>
Primary rat glomerular mesangial cells were isolated from Sprague-Dawley rat kidney cortex and cultured as previously described [18, 19]. The cells were cultured in DMEM containing 17% FBS, then routinely growth-arrested in 0.5% FBS for 48 hours in either normal D-glucose 5.6 mM or high D-glucose 25 mM, or 5.6 mM D-glucose + 24.4 mM L-glucose for up to 48 hours. In some experiments, cells were incubated with 10 muM rosiglitazone, 10 muM Ciglitazone, 10 muM Troglitazone, and/or pretreated with 10 muM GW9662 (a PPARgamma antagonist). AMPK activity was inhibited by pretreatment for 48 hours with 50 uM Compound C, a cell-permeable, selective ATP-competitive kinase inhibitor of AMPK [17, 20, 21]. The glitazone compounds were first dissolved in DMSO to create a 25.2 mmol/uL stock solution stored at -20degreesC and then dissolved in DMEM to produce a final concentration of 10 uM in the cell culture medium.
###end p 12
###begin title 13
2.3. Western Immunoblotting
###end title 13
###begin p 14
###xml 71 76 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 81 85 77 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 99 103 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 140 144 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
###xml 147 151 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 151 152 138 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 235 236 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 238 240 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
Western immunoblots were performed with primary antibodies against PPARgamma, p22phox, VEGF, AMPK, beta-actin in total cell lysates, or PKC-zeta, -beta1 in total cell lysates and cellular membrane fractions as we previously described [5, 15].
###end p 14
###begin title 15
2.4. Quantitative Real-Time Polymerase Chain Reaction
###end title 15
###begin p 16
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 392 396 392 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 530 535 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 661 665 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Total cellular RNA was extracted from mesangial cells using an RNeasy kit (Qiagen, Valencia, Calif, USA). After the RNA was reverse transcribed, real-time PCR was performed with the following primers as described previously [15]. The primers for VEGF were (sense), 5'-GATGAGATAGAGTATATCTTCAAGCCGT-3', and (antisense), 5'-TCTATCTTTCTTTGGTCTGCATTCAC-3' (GenBank: NM_031836). The primers for p22phox were (sense), 5'-TCCTCCACTTACTGCTGTCCGT-3', and (antisense), 5'-TCAATGGGAGTCCACTGCTCAC -3' (Genbank: MIM_131550).The primers for PPARgamma were (sense) 5'-CCAGAGTCTGCTGATCTGCGA-3', and (antisense), 5'-GCCACCTCTTTGCTCTGCTC-3' (Genbank: MIM_131550). The primers for beta-actin were (sense) 5'-AGGCCCCTCTGAACCCTAAG-3', and (antisense), 5'-CAACACAGCCTGGATGGCTAC-3' (Genbank: NM_031144).
###end p 16
###begin title 17
###xml 24 29 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
2.5. Measurement of PPARgammaPromoter Activity
###end title 17
###begin p 18
###xml 14 19 14 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 128 133 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 185 187 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 297 298 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</italic>
###xml 584 586 576 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 730 731 721 722 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 886 887 877 878 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 889 890 880 881 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 923 924 914 915 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
To assess PPARgamma function, mesangial cells were transiently transfected with a luciferase reporter gene containing three PPARgamma response elements and a thymidine kinase promoter [22] obtained from Addgene (Cambridge, Mass, USA). Cells were plated in 24 well plates and transfected with Fugene 6 (Roche, Indianapolis, Ind, USA) according to the manufacturer's instructions. For measurement of luciferase activity, the transfected mesangial cells were growth-arrested in 0.5% FBS in 5.6 mM or 25 mM D-glucose for up to 48 hours. In some experiments, 10 uM rosiglitazone or/and 10 muM GW9662 was added to the medium for 48 hours. The mesangial cells were then lysed on ice in a buffer containing glycylglycine 25 mM, pH 8, MgSO4 15 mM, EGTA 4 mM, 1% Triton X-100. Luciferase activity was detected in 50 uL of cell extract plus 100 uL of reaction buffer (glycylglycine 25 mM, pH 8, KH2PO4 15 mM, EGTA 4 mM, ATP 2 mM, MgSO4 15 mM, and CoA 0.1 mM) over 20 seconds in a plate reading luminometer. The results were normalized to total cell protein.
###end p 18
###begin title 19
2.6. Confocal Imaging
###end title 19
###begin p 20
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 199 203 <span type="species:ncbi:9925">goat</span>
###xml 209 215 <span type="species:ncbi:9986">rabbit</span>
To analyze collagen IV protein content, cells were cultured on glass coverslips and incubated with polyclonal antibody against collagen IV. The primary antibodies were detected using FITC-conjugated goat anti-rabbit IgG (Jackson Immunoresearch Laboratories, Inc; West Grove, Pa, USA). Immunofluorescence was observed by confocal imaging and fluorescence intensity per cell was analyzed as previously described [5, 15].
###end p 20
###begin p 21
###xml 121 123 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 132 133 131 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 384 385 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 387 389 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
To analyze hydrogen peroxide content, mesangial cells were cultured on glass coverslips and incubated in the dark with 1 muM of CM-H2DCFDA for 25 minutes at 37degreesC. Intracellular ROS production was detected by confocal laser scanning microscopy. Fluorescence intensity per cell was analyzed by Scion Image software (Scion Corporation, Frederick, Md, USA) as previously described [5, 15].
###end p 21
###begin title 22
2.7. Statistical Analyses
###end title 22
###begin p 23
###xml 152 153 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 386 387 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
 All results are expressed as mean +/- SEM. Statistical analyses were performed using Instat 2.01 (Graph Pad, Sacramento, Calif, USA). Unpaired Student t tests were used to compare the means of two groups. One-way analysis of variance (ANOVA) was performed to compare the means of three groups or more, then the Tukey-Kramer multiple comparison test was applied for post test analysis. P < .05 was considered to be statistically significant.
###end p 23
###begin title 24
3. Results
###end title 24
###begin title 25
###xml 54 59 54 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
3.1. Effects of High Glucose and Rosiglitazone on PPARgamma Expression
###end title 25
###begin p 26
###xml 33 38 33 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 297 302 293 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 319 332 311 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1"> Figure 1(a) </xref>
###xml 364 369 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 484 489 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 567 578 551 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1(b)</xref>
###xml 661 666 645 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 681 687 661 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947; </italic>
###xml 720 722 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 724 726 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 728 739 704 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1(c)</xref>
Mesangial cell expression of PPARgamma in high glucose was analyzed by incubating cells with 5.6 mM (normal glucose) or 25 mM (high glucose) D-glucose, or 5.6 mM D-glucose + 24.4 mM L-glucose for up to 48 hours, with and without rosiglitazone. L-Glucose exposure for 48 hours had no effect on PPARgamma mRNA expression. Figure 1(a) shows that in high glucose, PPARgamma protein expression was reduced by 3 hours and sustained up to 48 hours as demonstrated by Western immunoblot. PPARgamma mRNA levels were significantly reduced by 24 hours continuing up to 48 hours Figure 1(b). We also demonstrated that neither rosiglitazone nor GW6992 (an antagonist of PPARgamma), altered PPARgamma  protein levels in high glucose [17, 23] Figure 1(c).
###end p 26
###begin p 27
###xml 27 32 27 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 187 192 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 242 244 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 246 248 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 348 359 340 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1(d)</xref>
###xml 407 412 399 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 477 482 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 554 559 538 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 813 824 793 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1(e)</xref>
###xml 910 921 890 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1(f)</xref>
###xml 960 965 940 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1040 1045 1016 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1115 1126 1087 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1(f)</xref>
To investigate whether PPARgamma activation of transcription is reduced in high glucose and if rosiglitazone alters this response, mesangial cells were transiently transfected with a PPARgamma-luciferase reporter gene as described by others [24, 25]. Decreased luciferase activity was found at 1 to 48 hours of exposure to high glucose as shown in Figure 1(d). These data suggest that downregulation of PPARgamma expression in high glucose reduces the functional effect of PPARgamma on promoter activity. To determine whether rosiglitazone modulates PPARgamma stimulation of promoter activity, mesangial cells were pre-incubated with 1 to 20 uM rosiglitazone and promoter activity was measured. A maximum effect on luciferase activity was observed in normal glucose in the cells incubated with 5 uM rosiglitazone Figure 1(e), and in high glucose, 10 uM rosiglitazone stimulated luciferase to a similar maximum Figure 1(f). We then found that inhibition of PPARgamma receptor activity with GW6992 prevented the rosiglitazone-stimulated PPAR-gamma responsive promoter activity both in normal glucose and high glucose Figure 1(f).
###end p 27
###begin title 28
###xml 37 42 37 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
3.2. ROS Generation Regulated by PPARgamma
###end title 28
###begin p 29
###xml 93 101 93 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 266 277 266 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2(a)</xref>
###xml 349 360 349 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2(b)</xref>
 In high glucose, ROS generation appeared within 1 to 3 hours in DCF-loaded mesangial cells (Figure 2), as previously reported [5, 15]. We observed that 1 hour pretreatment with rosiglitazone abolished ROS generation during 3 to 48 hours of exposure to high glucose Figure 2(a). This effect of rosiglitazone was blocked by preincubation with GW9662 Figure 2(b). GW9662 alone caused generation of ROS in normal glucose. 
###end p 29
###begin p 30
###xml 52 56 52 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 138 143 138 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 188 192 184 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 326 328 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 367 378 362 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3(a)</xref>
###xml 383 387 378 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 538 542 533 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 673 678 668 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 731 735 722 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 767 778 758 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3(b)</xref>
We have reported that the NADPH oxidase subunit, p22phox is upregulated in high glucose in mesangial cells [15]. To determine whether PPARgamma activation modifies high glucose-induced p22phox expression, mesangial cells were exposed to 5.6 mM or 25 mM D-glucose for up to 48 hours. First, the cells were preincubated with 10 muM rosiglitazone alone. As displayed in Figure 3(a), p22phox protein levels in high glucose were increased as expected at 24 hours and 48 hours. Rosiglitazone not only prevented the effect of high glucose on p22phox protein but also reduced the ambient level of this protein in normal glucose. Further, cells were tested with three different PPARgamma activators that all blocked high glucose-induced p22phox protein expression as shown in Figure 3(b).
###end p 30
###begin title 31
3.3. Rosiglitazone Prevents High Glucose-Induced VEGF and Collagen IV Expression in Mesangial Cells
###end title 31
###begin p 32
###xml 26 31 26 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 299 310 295 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4(a)</xref>
###xml 445 456 441 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4(b)</xref>
###xml 598 610 594 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4(c) </xref>
###xml 667 672 663 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 878 889 870 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4(d)</xref>
To test the effect of PPARgamma activation and inhibition on VEGF expression, mesangial cells were growth-arrested and exposed to 5.6 mM or 25 mM D-glucose for up to 48 hours, with or without rosiglitazone or GW9662. The increase in VEGF mRNA levels was prevented by pretreatment with rosiglitazone Figure 4(a). Both Ciglitazone and Troglitazone also blocked high glucose-stimulated VEGF expression at 48 hours as detected by Western immunoblot Figure 4(b). Then, enhanced VEGF protein expression in high glucose was inhibited by pretreatment with 10 uM rosiglitazone at both 24 hours and 48 hours Figure 4(c) as detected by Western immunoblot. The inhibition of PPARgamma with GW9662 alone in normal glucose caused a significant increase in VEGF expression. Furthermore, this inhibitor reversed the effect of rosiglitazone on VEGF expression in mesangial cells in high glucose Figure 4(d). 
###end p 32
###begin p 33
###xml 109 114 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 320 331 316 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5(a)</xref>
###xml 520 531 516 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5(b)</xref>
To determine the effect of rosiglitazone on collagen IV expression, we first analyzed the effect of this PPARgamma activator on high glucose-induced mRNA expression. A significant increase in collagen IV mRNA was observed after 48 hours, but not 3 hours, in high glucose and this response was inhibited by rosiglitazone Figure 5(a). Intracellular collagen IV protein expression was assessed by immunofluorescence imaging. The increase in collagen IV protein at 3 and 24 hours was prevented by rosiglitazone pretreatment Figure 5(b).
###end p 33
###begin title 34
###xml 36 40 36 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 40 41 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 47 51 44 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
3.4. Effect of Rosiglitazone on PKC-beta1 and -zeta Membrane Translocation
###end title 34
###begin p 35
###xml 97 101 97 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 101 102 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 111 115 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
###xml 174 175 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 177 179 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 347 355 341 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6</xref>
###xml 434 438 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
###xml 452 456 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 456 457 444 445 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Since our previous studies indicated a cause-and-effect relationship among the activation of PKC-beta1 and PKC-zeta, ROS generation and both VEGF and collagen IV expression [5, 15], we wished to test whether rosiglitazone could affect these two key PKC isozymes that are relevant to the pathogenesis of diabetic glomerulophathy. As illustrated in Figure 6, in the presence of rosiglitazone, a reduction in membrane-association of PKC-zeta, but not PKC-beta1, was observed in both normal and high glucose. Total recoveries of both PKC isozymes in total cell lysate were unchanged in high glucose or in the presence of rosiglitazone.
###end p 35
###begin title 36
3.5. Rosiglitazone and the AMPK Pathway
###end title 36
###begin p 37
###xml 100 105 100 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 166 168 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 493 495 489 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 517 519 512 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 545 553 539 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7</xref>
 It has been reported that rosiglitazone reduces ROS production by NADPH oxidase independent of PPARgamma activity and that this effect may involve the AMPK pathway [17]. Thus, we determined whether inhibition of AMPK with Compound C would reverse the inhibition of ROS generation in response to HG observed during rosiglitazone treatment. Mesangial cells were growth-arrested and exposed to 5.6 mM or 25 mM D-glucose for up to 3 hours or 48 hours, with or without 1 hour pretreatment with 10 muM rosiglitazone or 50 muM Compound C, or both. In Figure 7, the effect of rosiglitazone on high glucose-induced ROS generation was reversed by coincubation with Compound C. Of note was that Compound C alone caused ROS generation in normal glucose at 48 hours. The enhanced generation of ROS by mesangial cells observed in high glucose at 3 and 48 hours was not affected by Compound C. However, in the presence of Compound C, the effect of rosiglitazone on ROS generation in high glucose was reversed in keeping with a possible AMPK-independent effect of Compound C on ROS generation.
###end p 37
###begin p 38
###xml 114 122 114 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Figure 8</xref>
###xml 714 725 714 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Figure 8(b)</xref>
The phosphorylation of AMPK in normal and high glucose at 3 hours was inhibited with Compound C as illustrated in Figure 8. In view of the generation of ROS during exposure to Compound C, these experiments were limited to 3 hours. VEGF protein expression in high glucose was also analyzed in the same protein samples. Rosiglitazone had no effect on AMPK phosphorylation in either normal or high glucose. While Compound C, as expected, inhibited AMPK phosphorylation in both normal and high glucose, it had no effect on VEGF expression in normal or high glucose. Furthermore, the inhibitory effect of rosiglitazone on enhanced VEGF expression at 3 hours in high glucose was not significantly affected by Compound C Figure 8(b).
###end p 38
###begin title 39
4. Discussion
###end title 39
###begin p 40
###xml 107 112 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 286 291 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 420 425 412 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 586 591 574 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 737 739 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 787 792 771 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 895 900 875 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 974 978 950 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1148 1153 1124 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
In this study, we identified that within the first 6 hours of exposure to high glucose, mesangial cell PPARgamma is downregulated and that rosiglitazone prevents the effects of high glucose on NADPH oxidase-dependent ROS generation, VEGF and collagen IV expression. The analysis of PPARgamma protein levels indicated a reduction as early as 3 hours following high glucose exposure, although significant reduction in PPARgamma mRNA levels was not detected until 6 hours, suggesting that high glucose may differentially alter translation and transcription. Differential regulation of PPARgamma protein and mRNA levels in high glucose could also be due to enhanced protein degradation following activation as demonstrated by Hauser et al. [26]. We demonstrated the dose response of the PPARgamma-stimulated promoter activity in response to increasing concentrations of rosiglitazone. Two other PPARgamma agonists, Ciglitazone and Troglitazone prevented high glucose-induced p22phox and VEGF expression. Our data support the conclusion that rosiglitazone prevents the effects of high glucose on mesangial cell signaling and gene expression through PPARgamma.
###end p 40
###begin p 41
###xml 106 110 106 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 261 266 261 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 493 498 489 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 569 571 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 591 593 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 616 621 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 877 882 865 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 887 892 871 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 995 997 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1014 1016 994 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1287 1291 1267 1271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1299 1303 1279 1283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 1335 1336 1315 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1338 1340 1318 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1408 1413 1388 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1447 1451 1423 1427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 989 993 <span type="species:ncbi:10116">rats</span>
###xml 1138 1142 <span type="species:ncbi:10090">mice</span>
We also found that rosiglitazone prevented high glucose-induced upregulation of NADPH oxidase subunit, p22phox expression, correlating with the effect of rosiglitazone in attenuating ROS generation in response to high glucose. Further, an antagonist of the PPARgamma receptor, GW9662, caused ROS generation in normal glucose and prevented the effects of rosiglitazone. These data also support the conclusion that the effects of rosiglitazone in mesangial cells are likely mediated through PPARgamma. Our findings agree with those recently reported by Henderson et al. [27] and Tyagi et al. [28] who found that a PPARgamma agonist (Ciglitazone) prevented the ROS generation that was associated with an upregulation of the NADPH oxidase subunit (Nox4) in response to pressure overload and homocysteine in myocardium and in endothelial cells, respectively. The combination of PPARalpha and gamma activators also inhibits angiotensin II-induced ROS production by NADPH oxidase in hypertensive rats [29]. Hwang et al. [30] recently reported that rosiglitazone reduces vascular oxidative stress and NADPH oxidase subunit expression in diabetic mice. We have shown that sustained production of ROS in mesangial cells in high glucose may be due to the upregulation of NADPH oxidase subunits, p47phox and p22phox via a PKC-dependent mechanism [5, 31]. The present study extends our findings to include a role for PPARgamma in the negative regulation of p22phox expression in mesangial cells in the normal state as well as reversal of the increase induced by high glucose.
###end p 41
###begin p 42
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 292 297 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 442 444 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 468 473 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 612 617 604 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 715 717 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 318 323 <span type="species:ncbi:9606">human</span>
Recently, we published that in high glucose the upregulation of VEGF expression by mesangial cells is dependent on ROS generation by NADPH oxidase [15]. Evidence is increasing for an important functional relationship between PPAR and VEGF. Xin et al. [32] reported that the activation of PPARgamma with Ciglitazone in human umbilical vein endothelial cells reduced VEGF receptor 1 (Flt1) and 2 (Flk/KDR) expression. Further, Meissner et al. [33] demonstrated that PPARalpha activators inhibit VEGF receptor 2 expression via inhibition of Sp1-dependent DNA binding and trans-activation. In endothelial cells, PPARgamma activators inhibited VEGF-induced AKT phosphorylation and consequent endothelial cell migration [34]. Our present data are consistent with these reports and show that rosiglitazone abolished high glucose-stimulated VEGF expression in mesangial cells. 
###end p 42
###begin p 43
###xml 329 334 329 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 380 382 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 393 398 389 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 464 466 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 506 511 498 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 576 578 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 609 614 597 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 654 658 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 658 659 639 640 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 728 730 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 732 734 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 792 797 773 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 858 860 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 918 923 895 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1050 1052 1023 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
###xml 472 477 <span type="species:ncbi:9606">human</span>
Our findings also illustrate that rosiglitazone prevented collagen IV expression by mesangial cells in high glucose. These results are in keeping with a number of studies relating PPAR activation to the prevention of extracellular matrix production relevant to kidney disease. Accelerated nephropathy is observed in diabetic PPARalpha-knockout mice due to collagen IV deposition [35]. The PPARalpha agonist fenofibrate prevents diabetic nephropathy in db/db mice [36]. In human kidney fibroblasts, the PPARgamma agonist, pioglitazone, reduces extracellular matrix production [37]. In mesangial cells, the PPARgamma agonist thiazolidinediones inhibit TGF-beta1-induced fibronectin expression and ameliorate diabetic nephropathy [38, 39]. In renal tubular cells, pioglitazone activation of PPARgamma exerts antifibrotic effects in the setting of high glucose [40]. These findings do not exclude the possibility that PPARgamma activation in vivo may also prevent the accumulation of collagen IV through suppression of plasminogen activator inhibitor-1 [41]. 
###end p 43
###begin p 44
###xml 41 46 41 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 150 154 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 154 155 147 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 161 165 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
###xml 257 261 247 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
###xml 306 310 293 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 310 311 294 295 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 434 438 418 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
###xml 551 552 532 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 554 556 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 597 602 578 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 636 640 613 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
###xml 672 677 646 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 802 807 772 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1065 1067 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1069 1071 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 1154 1156 1120 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1462 1467 1428 1429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1077 1082 <span type="species:ncbi:9606">human</span>
To identify the mechanism(s) whereby PPARgamma regulates mesangial cell signaling and gene expression, we examined the effect of rosiglitazone on PKC-beta1 and -zeta membrane-association patterns and on AMPK phosphorylation. The membrane-association of PKC-zeta was inhibited by rosiglitazone, whereas PKC-beta1 was unaffected. We previously demonstrated the cause-and-effect relationship between the activation of mesangial cell PKC-zeta in high glucose and subsequent generation of ROS, VEGF, and collagen IV expression in response to high glucose [5, 15]. Therefore, the observation that a PPARgamma activator appears to inhibit PKC-zeta membrane association links PPARgamma to this specific PKC isozyme pathway. By contrast, rosiglitazone had no effect on AMPK phosphorylation, suggesting that PPARgamma in mesangial cells may not signal through this pathway. These results differ from a recent report in which rosiglitazone was observed to reduce glucose-induced oxidative stress mediated by NADPH oxidase via an AMPK-dependent mechanism in endothelial cells [17, 42]. In human neutrophils, AMPK activation inhibits ROS generation by NADPH oxidase [23]. We observed that in high glucose, mesangial cell AMPK phosphorylation was reduced. Taken together with the observation that inhibition of AMPK with Compound C was associated with ROS generation, it is possible that AMPK regulates ROS generation in mesangial cells, but separately from the action of PPARgamma. It appears that the signaling response of AMPK in high glucose may vary depending on the cell phenotype. 
###end p 44
###begin p 45
###xml 34 39 34 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 126 130 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
###xml 188 193 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 212 216 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 239 243 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 367 369 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 371 373 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 470 474 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 476 478 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 499 503 479 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 581 586 558 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 636 641 609 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 783 785 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 793 795 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 797 799 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 827 829 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 835 840 804 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 843 845 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 924 929 889 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 997 1002 958 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1019 1023 976 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1096 1100 1050 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1216 1220 1167 1171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
The precise mechanism whereby PPARgamma inhibits high glucose-stimulated VEGF, ROS formation, collagen IV expression, and PKC-zeta is not known at present. A well-documented effect of PPARgamma is to inhibit TGF-beta expression and/or TGF-beta signaling giving rise to an antifibrotic effect, which can be demonstrated in vivo in models of lung fibrosis for example [38, 43]. Given that we have recently found that all of the above effects of high glucose depend on TGF-beta [44], inhibition of TGF-beta and its downstream signaling could account for the inhibitory effects of PPARgamma observed in the present study. Intriguingly, PPARgamma has been variably shown to prevent DNA binding, and in some cases to interact physically with different transcription factors, such as AP-1 [45], Sp1 [33, 46], nuclear factor-1 (NF-1) [47], NF-kappaB [48]. Therefore, one could hypothesize that suppression of AP-1, Sp1, NF-1, or NF-kappaB DNA binding could be sufficient to account for the effects of PPARgamma by reducing TGF-beta expression, interfering with the expression of proteins involved in TGF-beta signaling, and perhaps by directly affecting the expression of some of the above proteins, such as collagen IV, p22phox, and VEGF. 
###end p 45
###begin p 46
###xml 68 73 68 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 210 214 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
###xml 342 347 335 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 435 440 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
In summary, mesangial cells demonstrate rapid downregulation of PPARgamma via both transcriptional and nontranscriptional regulation in response to high glucose. Treatment with rosiglitazone, linked to the PKC-zeta pathway, attenuates high glucose-induced ROS generation and prevents VEGF and collagen IV expression through its action on PPARgamma. This study suggests that preventing the actions of high glucose on mesangial cell PPARgamma may be relevant in the treatment and prevention of diabetic glomerulopathy.
###end p 46
###begin title 47
Acknowledgments
###end title 47
###begin p 48
This work was supported by the Canadian Diabetes Association (C. Whiteside) and in part by grants from the Canadian Institutes of Health Research (CIHR) to I. G. Fantus (MOP 83025 and MOP 49409). L. Xia was a Post-doctoral fellow supported by the Canadian Diabetes Association and CIHR (MOP 49409).
###end p 48
###begin article-title 49
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Glomerular type IV collagen in patients with diabetic nephropathy with and without additional glomerular disease
###end article-title 49
###begin article-title 50
Extracellular matrix metabolism in diabetic nephropathy
###end article-title 50
###begin article-title 51
Overview of glucose signaling in mesangial cells in diabetic nephropathy
###end article-title 51
###begin article-title 52
The involvement of advanced glycation endproducts (AGEs) in renal injury of diabetic glomerulosclerosis: association with phenotypic change in renal cells and infiltration of immune cells
###end article-title 52
###begin article-title 53
###xml 29 33 29 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 33 34 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 44 48 41 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
Reactive oxygen species, PKC-beta1, and PKC-zeta mediate high-glucose-induced vascular endothelial growth factor expression in mesangial cells
###end article-title 53
###begin article-title 54
###xml 5 10 5 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 16 21 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse
###end article-title 54
###begin article-title 55
Drug insight: thiazolidinediones and diabetic nephropathy-relevance to renoprotection
###end article-title 55
###begin article-title 56
The mechanisms of action of PPARs
###end article-title 56
###begin article-title 57
The role of PPARs in the transcriptional control of cellular processes
###end article-title 57
###begin article-title 58
###xml 43 48 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 55 60 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 104 109 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 76 79 <span type="species:ncbi:10116">rat</span>
Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation
###end article-title 58
###begin article-title 59
###xml 84 89 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 95 100 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 148 152 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 156 161 <span type="species:ncbi:9606">human</span>
Early stimulation and late inhibition of peroxisome proliferator-activated receptor gamma (PPARgamma) gene expression by transformino growth factor beta in human aortic smooth muscle cells: role of early growth-response factor-1 (Egr-1), activator protein 1 (AP1) and Smads
###end article-title 59
###begin article-title 60
Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2
###end article-title 60
###begin article-title 61
Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione
###end article-title 61
###begin article-title 62
###xml 28 32 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 32 33 29 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 186 191 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 97 102 <span type="species:ncbi:9606">human</span>
Pioglitazone attenuates TGF-beta1-induction of fibronectin synthesis and its splicing variant in human mesangial cells via activation of peroxisome proliferator-activated receptor (PPAR)gamma
###end article-title 62
###begin article-title 63
Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression
###end article-title 63
###begin article-title 64
###xml 4 9 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 86 90 <span type="species:ncbi:10116">rats</span>
###xml 99 103 <span type="species:ncbi:10116">rats</span>
PPARgamma agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats
###end article-title 64
###begin article-title 65
Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism
###end article-title 65
###begin article-title 66
Stretch-induced mesangial cell ERK1/ERK2 activation is enhanced in high glucose by decreased dephosphorylation
###end article-title 66
###begin article-title 67
###xml 62 67 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#948;</italic>
###xml 73 80 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
Effect of high glucose on mesangial cell protein kinase and C-delta and -epsilon is polyol pathway-dependent
###end article-title 67
###begin article-title 68
###xml 127 132 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms
###end article-title 68
###begin article-title 69
###xml 134 138 <span type="species:ncbi:10116">rats</span>
Rosiglitazone treatment enhances acute AMP-activated protein kinase-mediated muscle and adipose tissue glucose uptake in high-fat-fed rats
###end article-title 69
###begin article-title 70
###xml 14 19 10 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12,14</sup>
###xml 35 36 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 92 97 88 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
15-deoxy-Delta12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARgamma
###end article-title 70
###begin article-title 71
###xml 77 82 <span type="species:ncbi:9606">human</span>
Stimulators of AMP-activated protein kinase inhibit the respiratory burst in human neutrophils
###end article-title 71
###begin article-title 72
###xml 44 49 44 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells
###end article-title 72
###begin article-title 73
###xml 52 57 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
Troglitazone and pioglitazone interactions via PPAR-gamma-independent and -dependent pathways in regulating physiological responses in renal tubule-derived cell lines
###end article-title 73
###begin article-title 74
###xml 62 67 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation
###end article-title 74
###begin article-title 75
Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone
###end article-title 75
###begin article-title 76
###xml 192 197 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
Ciglitazone ameliorates homocysteine-mediated mitochondrial translocation and matrix metalloproteinase-9 activation in endothelial cells by inducing peroxisome proliferator activated receptor-gamma activity
###end article-title 76
###begin article-title 77
###xml 69 74 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 83 88 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 142 146 <span type="species:ncbi:10116">rats</span>
Synergistic vascular protective effects of combined low doses of PPARalpha and PPARgamma activators in angiotensin II-induced hypertension in rats
###end article-title 77
###begin article-title 78
###xml 8 13 8 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice
###end article-title 78
###begin article-title 79
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</italic>
###xml 22 26 22 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>phox</italic></sup>
###xml 40 45 40 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 47 51 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 55 60 48 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#948;</italic>
###xml 66 70 55 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
###xml 96 100 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</italic>
###xml 96 100 82 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>phox</italic></sup>
Phosphorylation of p47phox sites by PKC alpha, betaII, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation
###end article-title 79
###begin article-title 80
Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo
###end article-title 80
###begin article-title 81
###xml 4 9 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation
###end article-title 81
###begin article-title 82
PPAR activators inhibit endothelial cell migration by targeting Akt
###end article-title 82
###begin article-title 83
###xml 96 101 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha
###end article-title 83
###begin article-title 84
###xml 4 9 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 63 65 59 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db</italic>
###xml 66 68 62 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db</italic>
PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mic
###end article-title 84
###begin article-title 85
###xml 67 72 <span type="species:ncbi:9606">human</span>
Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts
###end article-title 85
###begin article-title 86
###xml 43 48 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 69 73 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta1-induced fibronectin expression in glomerular mesangial cells
###end article-title 86
###begin article-title 87
Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms
###end article-title 87
###begin article-title 88
###xml 4 9 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
PPARgamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose
###end article-title 88
###begin article-title 89
Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1
###end article-title 89
###begin article-title 90
AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function
###end article-title 90
###begin article-title 91
###xml 5 10 5 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 54 59 <span type="species:ncbi:9606">human</span>
PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis
###end article-title 91
###begin article-title 92
###xml 27 31 27 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
###xml 72 76 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 76 77 70 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
High glucose activates PKC-zeta and NADPH oxidase through autocrine TGF-beta1 signaling in mesangial cells
###end article-title 92
###begin article-title 93
###xml 43 48 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells
###end article-title 93
###begin article-title 94
###xml 101 106 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-gamma via an interaction with Sp1 in vascular smooth muscle cells
###end article-title 94
###begin article-title 95
###xml 43 48 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 69 74 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
Peroxisome proliferator-activated receptor gamma suppresses proximal alpha1(I) collagen promoter via inhibition of p300-facilitated NF-I binding to DNA in hepatic stellate cells
###end article-title 95
###begin article-title 96
###xml 136 141 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 68 72 <span type="species:ncbi:10116">rats</span>
Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation
###end article-title 96
###begin p 97
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effect of high glucose on PPAR </italic>
###xml 31 36 31 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 36 48 32 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">expression. </italic>
###xml 207 212 203 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 272 276 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 333 338 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 378 383 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 434 435 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 444 445 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 465 466 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 510 512 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 544 546 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 586 591 565 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 633 634 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 641 642 616 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 873 874 848 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 881 882 856 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 902 903 877 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 937 943 912 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947; </italic>
###xml 996 997 967 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1004 1005 975 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1062 1063 1033 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1072 1073 1043 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1099 1100 1070 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1133 1134 1104 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 49 52 <span type="species:ncbi:10116">Rat</span>
Effect of high glucose on PPAR gammaexpression.  Rat glomerular mesangial cells were cultured in 5.6 mM (NG) or 25 mM D-glucose (HG), or 5.6 mM D-glucose + 24.4 mM L-glucose (LG) for up to 48 hours. (a) PPARgamma was detected by immunobloting in total cell lysates, using beta-actin as the loading controls. The graphs represent PPARgamma protein levels relative to NG. (b) PPARgamma mRNA levels were determined by real-time RT-PCR. (n = 4-6, *P < .05 versus NG; **P < .01 versus NG). (c) Preincubated with 10 muM rosiglitazone (RSG) or/and 10 muM GW9662, the protein expression of PPARgamma was not affected by RSG or GW6992 in HG (n = 5, *P < .05 versus NG). Mesangial cells were transiently transfected with a luciferase reporter gene containing three PPAR response elements and then cultured in the above conditions. (d) Luciferase reporter activity was reduced in HG (n = 5, *P < .05 versus NG, **P < .01 versus NG). (e) In NG, PPARgamma promoter activity increased in dose response to RSG (n = 4, *P < .01 versus NG). (f) GW6992 blocked the effect of RSG (n = 4-6, *P < .01 versus NG alone, **P < .05 versus NG or HG alone, ***P < .05 versus NG or HG with RSG).
###end p 97
###begin p 98
###xml 0 63 0 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effect of rosiglitazone on reactive oxygen species generation. </italic>
###xml 175 177 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 410 411 409 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 430 431 429 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 452 453 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 563 564 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 583 584 582 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 605 606 604 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 680 682 679 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
Effect of rosiglitazone on reactive oxygen species generation.  Mesangial cells were exposed to 5.6 mM (NG) or 25 mM (HG) D-glucose for up to 48 hours, and pretreated with 10 muM rosiglitazone (RSG) or GW9662 for 1 hour. Reactive oxygen species (ROS) were detected in DCF-loaded cells by confocal fluorescence imaging in 3 or 4 separate experiments for each condition. (a) ROS generation was inhibited by RSG (n = 147-218 cells, *P < .001 versus NG, **P < .001 versus HG 3 hours, HG 24 hours, or HG 48 hours). (b) ROS generation in NG was stimulated with GW9662 (n = 130-189 cells, *P < .001 versus NG, **P < .001 versus HG 48 hours without RSG or GW9662). Magnification bar = 25 muM.
###end p 98
###begin p 99
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NADPH oxidase subunit </italic>
###xml 26 30 26 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 30 43 30 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> expression. </italic>
###xml 160 162 160 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 191 193 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 213 215 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 238 242 235 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 313 318 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 350 354 343 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 367 368 360 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 375 376 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 396 397 389 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
NADPH oxidase subunit  p22phox expression.  Mesangial cells were exposed to 5.6 mM (NG) or 25 mM (HG) D-glucose for 24 hours or 48 hours, or pretreated with 10 muM rosiglitazone (RSG), or 10 muM ciglitazone or 10 muM troglitazone) and p22phox was detected by immunoblotting. Pretreatment with three different PPARgamma agonists blocked HG-induced p22phox expression (n = 5, *P < .05 versus NG, **P < .05 versus HG 24 hours or HG 48 hours).
###end p 99
###begin p 100
###xml 0 60 0 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rosiglitazone prevented high glucose-induced VEGF expression</italic>
###xml 176 181 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 195 197 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 218 220 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 242 244 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 316 317 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 324 325 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 345 346 338 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 407 412 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 509 510 498 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 517 518 506 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 538 539 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 707 711 696 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 799 800 785 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 807 808 793 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 828 829 814 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 888 889 874 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 896 897 882 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 939 940 925 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Rosiglitazone prevented high glucose-induced VEGF expression. Mesangial cells were placed in 5.6 mM (NG) or 25 mM (HG) D-glucose for the indicated times or pretreated with PPARgamma agonists (10 muM Ciglitazone, or 10 muM Troglitazone, or 10 muM RGS) for 1 hour. (a) VEGF mRNA levels were detected by real-time PCR (n = 4, *P < .05 versus NG, **P < .01 versus HG). (b) Pretreatment with three different PPARgamma agonists similarly blocked HG-induced VEGF expression at 48 hours as detected by immunobloting (n = 4, *P < .01 versus NG, **P < .01 versus HG). (c) Rosiglitazone alone prevented HG-induced VEGF expression at both 24 hours and 48 hours as detected by immunoblotting in total cell lysates using beta-actin as the loading control. The graphs represent VEGF protein levels relative to NG (n = 5, *P < .01 versus NG, **P < .01 versus HG). (d) GW9662 reverses the effect of RSG, (n = 5, *P < .01 versus NG without RSG or GW9662, **P < .001 versus NG without RSG or GW9662).
###end p 100
###begin p 101
###xml 0 67 0 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rosiglitazone prevented high glucose-induced collagen IV expression</italic>
###xml 165 167 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 236 241 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 283 284 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 291 292 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 461 462 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 481 482 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 524 526 519 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
Rosiglitazone prevented high glucose-induced collagen IV expression. Mesangial cells were exposed to 5.6 mM (NG) or 25 mM (HG) for up to 48 hours pretreated with 10 muM rosiglitazone (RSG) for 1 hour. (a) The expression of collagen IV (alpha1) mRNA was detected by real-time RT-PCR (n = 4, *P < .05 versus NG). (b) Representative confocal microscopic images show collagen IV staining without (C) or with RSG. Immunofluorescence intensity per cell was analyzed (n = 76-136 cells, **P < .01 versus NG). Magnification bar = 25 muM.
###end p 101
###begin p 102
###xml 4 8 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 8 9 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 18 22 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
###xml 0 65 0 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKC-<italic>&#946;</italic><sub>1</sub> and PKC-<italic>&#950;</italic> response to high glucose and rosiglitazone</italic>
###xml 168 170 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 208 212 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 212 213 202 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 222 226 212 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
###xml 344 348 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 348 349 332 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 358 362 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</italic>
###xml 410 411 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 418 419 399 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 451 452 432 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
PKC-beta1 and PKC-zeta response to high glucose and rosiglitazone. Mesangial cells were exposed to 5.6 mM (NG) or 25 mM (HG) for 3 hours or 48 hours pretreated with 10 muM rosiglitazone (RSG) for 1 hour. PKC-beta1 and PKC-zeta were detected in total cell lysates or membrane fractions with immunoblotting. (a) Representative immunoblots of PKC-beta1 and PKC-zeta. (b) Quantitative analysis of the immunoblots (n = 5, *P < .05 versus NG without RSG, **P < .01 versus HG without RSG).
###end p 102
###begin p 103
###xml 0 99 0 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Compound C reversed rosiglitazone prevented high glucose-induced reactive oxygen species generation</italic>
###xml 212 214 212 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 242 244 241 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 509 510 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 529 530 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 583 584 581 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 659 661 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
Compound C reversed rosiglitazone prevented high glucose-induced reactive oxygen species generation. Mesangial cells were exposed to 5.6 mM (NG) or 25 mM (HG) for 3 hours or 48 hours, and then pretreated with 10 muM rosiglitazone (RSG) or 50 muM compound C (CPC), or combination of both, for 1 hour. Reactive oxygen species (ROS) generation was measured in DCF-loaded cells using confocal fluorescence imaging. RSG prevented high glucose stimulated ROS production that was abolished by coincubation with CPC (n = 145-204 cells, *P < .05 versus NG in the absence of RSG and/or CPC, **P < .01 versus HG in the absence of RSG and/or CPC). Magnification bar = 25 muM.
###end p 103
###begin p 104
###xml 0 69 0 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effects of Compound C on AMP kinase activity and VEGF in high glucose</italic>
###xml 170 172 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 200 202 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 540 541 538 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 548 549 546 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 577 578 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 634 635 632 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Effects of Compound C on AMP kinase activity and VEGF in high glucose. Mesangial cells were exposed to 5.6 mM (NG) or 25 mM (HG) for 3 hours, and then pretreated with 10 muM rosiglitazone (RSG) or 50 muM compound C (CPC), or combination of both, for 1 hour. Total AMP kinase (T-AMPK), phosphorylated AMPK (P-AMPK) and VEGF were detected in the same total cell lysate samples with immunoblotting. CPC inhibited phosphorylation of AMPK in NG and HG, but had no effect on the inhibition of VEGF expression in HG. RSG had no effect on P-AMPK. (n = 3, *P < .05 versus VEGF in NG, **P < .05 versus VEGF in HG 3 hours without RSG or CPC, ***P < .05 versus P-AMPK in HG 3 hours without RSG or CPC).
###end p 104

